首页> 外文期刊>BMC Ophthalmology >Efficacy, predictability, and safety of small incision lenticule extraction: 6-months prospective cohort study
【24h】

Efficacy, predictability, and safety of small incision lenticule extraction: 6-months prospective cohort study

机译:小切口小孔摘除术的功效,可预测性和安全性:6个月的前瞻性队列研究

获取原文
       

摘要

Background To report our experience with small incision lenticule extraction ("SMILE") for myopia treatment. Methods In this prospective clinical study, we evaluated 447 eyes from 224 patients with myopia, with and without astigmatism. We followed the patients for 6?months after SMILE. Results The mean (±standard deviation, SD) spherical equivalent was -6.75?±?1.65 diopters (D) preoperatively and -0.21?±?0.37 D at 6?months postoperatively. Our data showed that 97.9% of eyes were within ±1.0 D and 86.1% were within ±0.5 D of the intended correction. Furthermore, 79.8% had an uncorrected distance visual acuity (UDVA) of 0 logMAR or less (20/20 or better in the Snellen equivalent) 6?months after surgery. Additionally, 48.5% remained unchanged, 41% gained one line of corrected distance visual acuity (CDVA), 7.2% gained two lines of CDVA, 3.3% lost one line of CDVA, and 0.3% lost two or more lines of CDVA. Age was the only predictor for worsening UDVA at 6?months postoperatively in linear regression analyses (0.07 decrease logMAR per increased 10?years of age; P? Conclusions SMILE is an effective and safe refractive surgery. Age was the only predictor that influenced visual outcome, but its effect appeared clinically insignificant. Faster visual recovery is also expected with improved surgical technique.
机译:背景报道我们在小切口小孔镜摘除术(“ SMILE”)用于近视治疗方面的经验。方法在这项前瞻性临床研究中,我们评估了224眼有或没有散光的近视患者的447眼。我们在SMILE后随访患者6个月。结果术前平均球度当量(±标准偏差,SD)为-6.75±±1.65 D(屈光度),术后6个月为-0.21±±0.37D。我们的数据显示,有97.9%的眼睛在预期矫正度的±1.0 D之内,有86.1%的眼睛在±0.5 D之内。此外,有79.8%的患者在术后6个月的未矫正远视力(UDVA)为0 logMAR或更低(在Snellen等效系统中为20/20或更高)。此外,有48.5%保持不变,有41%的人获得了1行矫正远视力(CDVA),有7.2%的人获得了2行CDVA,3.3%的人失去了1行CDVA,0.3%的人失去了2行或更多行CDVA。在线性回归分析中,年龄是术后6个月UDVA恶化的唯一预测因素(每增加10岁,logMAR降低0.07,PMAR结论:SMILE是一种有效且安全的屈光手术,年龄是影响视力结果的唯一预测因素,但其临床效果似乎微不足道,而且随着手术技术的改善,视觉恢复也有望更快。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号